Cedars-Sinai Medical Center in Los Angles has announced a $25 million gift from the Alfred E. Mann Charities to advance the field of precision medicine and single-cell biology research.

The largest single gift from the foundation established in 2014 by Giving Pledger Alfred E. Mann—founder of the biopharmaceutical company MannKind, who died in 2016—will establish the Alfred E. Mann Single Cell Precision Medicine Center, which aims to accelerate Cedars-Sinai’s research capacity with laboratories focused on the causes of developmental, neurological, immunological, cardiovascular, pulmonary, and gastrointestinal diseases and the development of new treatments for a broad array of challenging illnesses.

“There’s no question that this contribution is what Alfred Mann would have envisioned in his unwavering commitment to furthering health care with new and innovative treatments and technologies,” said Mann Charities board member Michael Dreyer.

“This generous gift will propel groundbreaking research,” said Cedars-Sinai executive vice president of academic affairs and dean of the medical faculty Shlomo Melmed. “Single cell biology is a rapidly growing field in medicine and Cedars-Sinai continues to position itself as an innovative leader in this exciting field, driving clinical innovation for our patients.”

(Photo credit: Getty Images/janiecbros)